Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)

China · Delayed Price · Currency is CNY

2.690

-0.060 (-2.18%)

Jul 21, 2026, 3:04 PM CST

-11.51% (1Y)

Market Cap	4.04B -11.6%
Revenue (ttm)	7.25B -5.9%
Net Income	14.35M +55.8%
EPS	0.01 +19.5%
Shares Out	1.47B
PE Ratio	281.63
Forward PE	n/a
Dividend	0.00 (0.07%)
Ex-Dividend Date	Jun 30, 2026

Volume	43,347,687
Open	2.820
Previous Close	2.750
Day's Range	2.640 - 2.820
52-Week Range	2.380 - 4.690
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHE:002589

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug and Equipment Distribution, In Vitro Diagnostics, Pharmaceutical Logistics, Traditional Chinese Medicine, and Microbiome Medicine segments. The company engages in the processing, manufacture, sale, and wholesale of Chinese medicinal materials, herbal medicine, and patent medicine. It is also involved in the wholesale of biochemical, psychotropic, narcotic, and toxic drugs for medical use... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 2004

Employees 2,407

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002589

Full Company Profile

Financial Performance

In 2025, SHE:002589's revenue was 7.30 billion, a decrease of -8.42% compared to the previous year's 7.97 billion. Earnings were 16.07 million, an increase of 30.73%.

Financial Statements